In this short video Professor Oliver FitzGerald from the University College Dublin, Ireland, discusses the findings of two pivotal studies on the use of tofacitinib (Xeljanz) in patients with psoriatic arthritis.
Two pivotal studies pave the way for tofacitinib (Xeljanz) in PsA: expert
Medicines
Sponsored by Pfizer Australia Pty Ltd
17 Oct 2019